Gene A is normally expressed in both liver cells and kidney cells. A patient is found to have a mutation in the regulatory region of Gene A. The clinical result is that Gene A is expressed at normal levels in the liver, but is completely absent in the kidney. Where is the mutation most likely located?

Question

Gene A is normally expressed in both liver cells and kidney cells. A patient is found to have a mutation in the regulatory region of Gene A. The clinical result is that Gene A is expressed at normal levels in the liver, but is completely absent in the kidney. Where is the mutation most likely located?

BlackTom AI · Accepted Answer

We are given a gene normally expressed in both liver and kidney, but a regulatory-region mutation causes normal expression in liver yet complete loss of expression in kidney. This pattern points to a tissue-specific regulatory element rather than a global component of transcription or mRNA processing.
Option 1: In a distal enhancer element specific for kidney-specific activators. This fits the scenario: an enhancer that responds to kidney-specific transcription factors drives expression in kidney. If this enhancer is mutated, kidney expression would drop while liver expression (driven by liver-specific factors and other regulatory elements) could remain normal. So this option explains tissue-specific loss.
Option 2: In the poly-A signal sequence. The poly-A signal affects mRNA 3' end processing and stability; a mutation here would more likely impact mRNA maturation broadly, potentially affecting transcripts in multiple tissues, not selectively abolishing kidney expression while leaving liver expression intact. This doesn't explain tissue-specific silencing.
Option 3: In the TATA Box of the promoter. A promoter TATA box mutation would generally reduce or abolish transcription across all tissues where the gene is active, not leave liver expression intact. The observed pattern suggests a regulatory element controlling tissue specificity rather than core promoter function.
Option 4: In the protein-coding exon region of the gene. A coding sequence mutation would typically alter the protein in all tissues where the transcript is produced (and may be lethal or severely deleterious), not selectively eliminate kidney expression while preserving liver expression. This mismatch makes it unlikely.
In summary, the kidney-specific enhancer mutation (Option 1) best accounts for normal liver expression with absent kidney expression due to loss of a tissue-specific regulatory input, whereas all other options would produce broader or different defects not aligned with the described phenotype.

Bio 93 Section CDE 2025 Final- Section E

View Explanation

Log in for full answers

Similar Questions

Question at position 22 Alterations to DNA sites such as promoters and operators can actonly in trans.These terms apply only to posttranscriptional regulation.only in cis.either in trans or in cis.Clear my selection

Why does the introduction of a liver-specific "activator" protein into a skin cell not immediately cause the skin cell to start producing all liver-specific proteins?

Question at position 74 Which of the following would result in decreasing levels of transcription of a gene?activator binding to the promoter or enhancer regioneuchromatinmethylation of DNAacetylation of the histone tail

Question at position 6 E.coli grown with the only nutrient as lactose will have what bound to it’s lac operon?CRP-cAMP onlyRepressor and inducer.CRP onlyrepressorinducerClear my selection

More Practical Tools for Students Powered by AI Study Helper

Homework AI Solver

Stylized AI Paper Writer

Plagiarism Checker Assistant

Citation AI Academic Writing Tool

In-Class Translation Assistant

AI Note Generator

AI Quiz Answers

Past Exam Questions from University Test Bank

Smart Practice Assistant

Adaptive Practice

Making Your Study Simpler